SOPHiA GENETICS, Inc. News Releases https://d25wby5c7p9100.cloudfront.net/public/uploads/44c1a6f786b473b4674fcb24ff2e3f0e/companies/logos/44c1a6f786b473b4674fcb24ff2e3f0e/avatar/Logo-SG_Vert_Blue_8x_%281%29.png?1660119893 https://careers.sophiagenetics.com/ Mon, 15 Jul 2024 07:10:14 +0000 PageUp http://cyber.harvard.edu/rss/rss.html Highlights include: a memorandum of understanding with Memorial Sloan Kettering Cancer Center and a novel new partnership with Boundless Bio, a next-generation precision oncology company SOPHiA GENETICS’ next-generation solution CarePath, fueled by current real world observational data, was Wed, 21 Sep 2022 11:02:08 +0000 4921451981cecf376415abe13dfd2d95 https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/sophia-genetics-unveils-strategy-to-drive-health-care-innovations-at-inaugural-investor-day-event BOSTON and GENEVA, Switzerland, Sept. 20, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space, will host its first-ever Investor Day TODAY in-person at PUBLIC Hotel in New York City. The event will begin at 1:30 p.m. Tue, 20 Sep 2022 10:43:29 +0000 ed6da32e8628c093beafccd091c89c20 https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/sophia-genetics-to-highlight-innovations-and-announcements-at-investor-day-on-september-20-2022 BOSTON and LAUSANNE, Switzerland, Sept. 02, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company in the healthcare space, announced today Chief Executive Officer, Dr. Jurgi Camblong and Chief Financial Officer, Ross Muken will participate in a fireside chat at Fri, 02 Sep 2022 11:00:07 +0000 fc67dacb876a25a037dd71553af1f034 https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/sophia-genetics-to-participate-in-fireside-chat-at-20th-annual-morgan-stanley-global-healthcare-conference Steady Operational Performance Amidst Macroeconomic Headwinds BOSTON and LAUSANNE, Switzerland, Aug. 09, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company in the healthcare space, today reported financial results for the second quarter ended June 30, 2022. Tue, 09 Aug 2022 11:05:29 +0000 07fc961e560255b57f10e888bb9f4189 https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/sophia-genetics-reports-financial-results-for-the-second-quarter-of-fiscal-2022 BOSTON and LAUSANNE, Switzerland, Aug. 04, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company in the healthcare space, announced today it will host its first-ever Investor Day on Tuesday, September 20, 2022, at PUBLIC Hotel in New York City. Thu, 04 Aug 2022 14:16:28 +0000 f973713b1931831e507b02b6ff6a1793 https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/sophia-genetics-to-host-investor-day-on-september-20-2022-in-new-york-city BOSTON and LAUSANNE, Switzerland, July 29, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a leader in data-driven medicine, announced today Chief Financial Officer, Ross Muken, will attend and be a panelist at the Canaccord Genuity 42 nd Annual Growth Conference on Thursday, August 11, Fri, 29 Jul 2022 11:00:32 +0000 dba9be73d189a9af721eb64385770f8f https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/sophia-genetics-to-participate-in-canaccord-genuity-42nd-annual-growth-conference BOSTON and LAUSANNE, Switzerland, July 14, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a leader in data-driven medicine, today announced it will release its financial results for the second quarter of fiscal 2022 before U.S. markets open on Tuesday, August 9, 2022. Thu, 14 Jul 2022 11:00:10 +0000 f4e40573b3381867b29454dc5a5316ec https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/sophia-genetics-to-announce-financial-results-for-the-second-quarter-of-fiscal-2022-on-august-9-2022 BOSTON and LAUSANNE, Switzerland , June 15, 2022 /PRNewswire/ -- SOPHiA GENETICS SA (Nasdaq: SOPH) (" the Company "), is pleased to announce the Annual General Meeting (" the Meeting ") was held at the Company's headquarters, rue du Centre 172, 1025 St-Sulpice, VD, Switzerland , earlier today at Wed, 15 Jun 2022 15:15:00 +0000 3f75997c0a25b6869e892a6d548c7fca https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/sophia-genetics-publishes-results-of-2022-annual-general-meeting BOSTON and LAUSANNE, Switzerland , June 15, 2022 /PRNewswire/ -- SOPHiA GENETICS SA (Nasdaq: SOPH) ("the Company"), today announced that the Company has published its first Environmental, Social and Governance Impact Summary ("ESG Impact Summary"). The ESG Impact Summary highlights the Company's Wed, 15 Jun 2022 13:55:00 +0000 1a9364995fac3fe61b722b8a8a9a5bfd https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/sophia-genetics-publishes-environmental-social-and-governance-impact-summary BOSTON and LAUSANNE, Switzerland , June 9, 2022 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), the Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) of Barcelona , and the Spanish Diagnóstica Longwood today announced from the European Hematology Association Congress in Vienna that Thu, 09 Jun 2022 12:00:00 +0000 a445e9ce05b544d8c9eea574ff8df322 https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/sophia-genetics-launches-new-solution-to-advance-chronic-lymphocytic-leukemia-care-in-collaboration-with-idibaps BOSTON and GENEVA, Switzerland, Oct. 06, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space, today announced it will release its financial results for the third quarter of fiscal 2022 before U.S. Thu, 06 Oct 2022 11:01:34 +0000 c9cc465b652a6b46480584911f63df47 https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/sophia-genetics-to-announce-financial-results-for-the-third-quarter-of-fiscal-2022-on-november-8-2022 BOSTON and LAUSANNE, Switzerland, Nov. 04, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company in the healthcare space, announced today the company will be participating in the following investor conferences. Evercore ISI HealthCONx Virtual Conference; Fri, 04 Nov 2022 10:49:30 +0000 a2c17366ba5ae9fe8a7fea346f35adde https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/sophia-genetics-to-participate-in-upcoming-november-investor-conferences Sustainable growth momentum evident despite foreign exchange headwinds BOSTON and LAUSANNE, Switzerland, Nov. 08, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company in the healthcare space, today reported financial results for the third quarter ended Tue, 08 Nov 2022 11:59:50 +0000 9b093f2c29f31c9509a31449ec8ec377 https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/sophia-genetics-reports-financial-results-for-the-third-quarter-of-fiscal-2022 BOSTON & LAUSANNE, Switzerland --(BUSINESS WIRE)--Jan. 4, 2023-- SOPHiA GENETICS SA (NASDAQ: SOPH) today announced that Dr. Jurgi Camblong, Chief Executive Officer and Co-Founder, is scheduled to present at the J.P. Morgan 2023 Healthcare Conference on Tuesday, January 10, 2023 , at 8:15 a.m. Wed, 04 Jan 2023 21:02:00 +0000 b2c84cbe033290b4275bec1e748adc38 https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/sophia-genetics-to-present-at-the-j-p-morgan-2023-healthcare-conference GENEVA --(BUSINESS WIRE)--Jan. 10, 2023-- SOPHiA GENETICS™ (Nasdaq: SOPH), a cloud-native software company in the healthcare space, has entered an agreement with Memorial Sloan Kettering Cancer Center (MSK) to offer clinicians and researchers new solutions to expand their testing and analytical Tue, 10 Jan 2023 13:03:00 +0000 39f96fc202c74d42e6edb507373800dc https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/sophia-genetics-and-leading-us-cancer-center-collaborate-to-combine-cancer-analysis-technology-for-liquid-biopsies The expanded partnership aims to leverage the global SOPHiA DDM™ platform and multimodal algorithmic capab ilities to lead a new era of precision oncology by improving early patient identification and diagnosis, optimizing clinical development, and accelerating adoption of innovative medications Mon, 13 Feb 2023 14:00:00 +0000 d8030b439e43325d3d289223882ba9dd https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/sophia-genetics-expands-partnership-with-astrazeneca-to-include-multimodal-approaches-for-cancer-drug-development BOSTON & LAUSANNE, Switzerland --(BUSINESS WIRE)--Feb. 23, 2023-- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space, today announced it will release its financial results for the fourth quarter and full year of fiscal 2022 before U.S. Thu, 23 Feb 2023 21:40:00 +0000 3e1ef8e75df0800cda9f57efef0107d1 https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/sophia-genetics-to-announce-financial-results-for-the-fourth-quarter-and-full-year-of-fiscal-2022-on-march-7-2023 The New Solution uses SOPHiA DDM™ and aims to Benefit Cancer Research , Clinical Studies and Patient Care BOSTON & LAUSANNE, Switzerland --(BUSINESS WIRE)--Feb. 28, 2023-- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space, today announced that Synergy Oncology, Tue, 28 Feb 2023 14:00:00 +0000 38044eb3ef2f4e4d385bbe575f751b46 https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/synergy-laboratories-taps-sophia-genetics-technology-for-new-cancer-profiling-solution BOSTON & LAUSANNE, Switzerland --(BUSINESS WIRE)--Mar. 1, 2023-- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space, today announced a new partnership with QIAGEN N.V. (NYSE: QGEN) that will pair QIAseq reagent technology with the SOPHiA DDM ™ platform to Wed, 01 Mar 2023 14:00:00 +0000 2a0fcd6010b97c4ef3129c68d81f68e3 https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/sophia-genetics-and-qiagen-forge-partnership-to-combine-strengths-in-next-generation-sequencing Fourth Quarter Revenue Growth Accelerates; Operating Losses Notably Moderate BOSTON & LAUSANNE, Switzerland --(BUSINESS WIRE)--Mar. 7, 2023-- SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company in the healthcare space, today announced financial results for its fourth quarter and full Tue, 07 Mar 2023 12:00:00 +0000 5de931c48ee41358edb0471aaef40ed3 https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/sophia-genetics-reports-fourth-quarter-and-year-end-2022-financial-results BOSTON & LAUSANNE, Switzerland --(BUSINESS WIRE)--Mar. 6, 2023-- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and the leader in data-driven medicine, today announced the University of Arkansas for Medical Sciences (UAMS), based in Little Rock, AR , will use SOPHiA GENETICS’ Mon, 06 Mar 2023 14:00:00 +0000 7371f44e5339f75d76bf13f929d2081d https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/university-of-arkansas-for-medical-sciences-will-use-sophia-genetics-to-advance-clinical-research-for-blood-cancers Collaboration provides a solution for a more in-depth analysis of cancer biomarkers BOSTON & LAUSANNE, Switzerland --(BUSINESS WIRE)--Mar. 14, 2023-- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and the leader in data-driven medicine, is partnering with Tue, 14 Mar 2023 13:00:00 +0000 64002c6d0200307ad39b7aaecc33c25b https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/sophia-genetics-and-agilent-partner-on-comprehensive-solution-for-cancer-analysis The New Assay Will Screen Patients for Clinical Trials and Help Increase Data Analysis for Clinical Researchers BOSTON & LAUSANNE, Switzerland --(BUSINESS WIRE)--Mar. 28, 2023-- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven Tue, 28 Mar 2023 13:00:00 +0000 a7ff38cafe461f09a6e9bbece2c9d0ad https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/acutis-diagnostics-leverages-sophia-genetics-technology-to-create-new-next-generation-sequencing-test SOPHiA DDM TM HRD Solution will help empower clinical researchers to advance cancer research BOSTON & LAUSANNE, Switzerland --(BUSINESS WIRE)--Apr. 4, 2023-- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced Tue, 04 Apr 2023 13:00:00 +0000 97822d508c2217a8793d55dd8edf6554 https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/tel-aviv-sourasky-medical-center-chooses-sophia-ddmtm-hrd-solution-of-sophia-genetics SOPHiA DDM™ for Hereditary Cancers Enables Krsnaa Diagnostics to Expand its NGS Offerings BOSTON & LAUSANNE, Switzerland --(BUSINESS WIRE)--Apr. 11, 2023-- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced Tue, 11 Apr 2023 13:00:00 +0000 3d2f6db9711327c04b10082821e2df46 https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/krsnaa-diagnostics-is-live-on-sophia-genetics SOPHiA GENETICS supports The University of Maryland Medical Center to advance their rare disease research BOSTON & LAUSANNE, Switzerland --(BUSINESS WIRE)--Apr. 18, 2023-- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, Tue, 18 Apr 2023 13:00:00 +0000 d20df679a2dfd6290d3f5cd98d2dbefd https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/the-university-of-maryland-medical-center-chooses-sophia-genetics-technology BOSTON and GENEVA, Switzerland, April 25, 2023 (GLOBE NEWSWIRE) -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space, today announced it will release its financial results for the first quarter of fiscal 2023 before U.S. markets open on Tuesday, May 9, 2023. Tue, 25 Apr 2023 11:11:07 +0000 43e714f0235c0690690bbd482b2e4fc4 https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/sophia-genetics-to-announce-financial-results-for-the-first-quarter-of-fiscal-2023-on-may-9-2023 Strong growth momentum and efficient expense execution continues BOSTON and LAUSANNE, Switzerland, May 09, 2023 (GLOBE NEWSWIRE) --  SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company in the healthcare space, today reported financial results for the first quarter ended March 31, Tue, 09 May 2023 10:55:48 +0000 b54b941ea958aca68fae0fbe6d6a4fd6 https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/sophia-genetics-reports-financial-results-for-the-first-quarter-of-fiscal-2023 SOPHiA DDM™ deep-learning algorithm will help determine HRD status of tumors for Institute of Oncology Ljubljana researchers BOSTON and LAUSANNE, Switzerland , May 24, 2023 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in Wed, 24 May 2023 10:00:00 +0000 efb887817ef5d787c0d525780861b1c6 https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/institute-of-oncology-ljubljana-leverages-sophia-ddm-platform-for-cancer-research BOSTON and ROLLE, Switzerland , June 26, 2023 /PRNewswire/ -- SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, is pleased to announce that its Annual General Shareholders Meeting (the "AGM ") was held at the Company's Mon, 26 Jun 2023 15:03:00 +0000 eefc2d2b4d537909cc4a3e568c3d7b59 https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/sophia-genetics-publishes-results-of-2023-annual-general-meeting SOPHiA DDM™ Platform will bring next-generation sequencing in-house and help further research on   hematologic malignancies BOSTON and ROLLE, Switzerland , July 7, 2023 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today Fri, 07 Jul 2023 10:04:00 +0000 af999e35d4fd0486fdaef27fa20a3301 https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/centre-hospitalier-de-bastia-is-live-on-sophia-genetics BOSTON and ROLLE, Switzerland , July 25, 2023 /PRNewswire/ -- SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company in the healthcare space, today announced it will release its financial results for the second quarter of fiscal 2023 before U.S. markets open on Tuesday, August 8, 2023 . Tue, 25 Jul 2023 11:35:00 +0000 858cea1b958143f35ca4049eb43f6eed https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/sophia-genetics-to-announce-financial-results-for-the-second-quarter-of-fiscal-2023-on-august-8-2023 CSM is using the SOPHiA DDM™ Platform to expand its next-generation sequencing (NGS) offerings BOSTON and ROLLE, Switzerland , July 13, 2023 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced Gruppo Centro Servizi Thu, 13 Jul 2023 10:09:00 +0000 ed72d1ce230f60de8f85a48d09e4f30a https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/sophia-genetics-announces-gruppo-centro-servizi-medici-csm-is-live-on-the-sophia-ddm-platform Robust growth and efficient expense execution continues BOSTON and ROLLE, Switzerland, Aug. 08, 2023 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today reported financial results for the second quarter ended June 30, Tue, 08 Aug 2023 11:10:29 +0000 eaade913002b69df911b40ba1250618f https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/sophia-genetics-reports-financial-results-for-the-second-quarter-of-fiscal-2023 Gustave Roussy uses SOPHiA DDM™ Platform to empower confident, data-driven medicine in the fight against cancer BOSTON and ROLLE, Switzerland , Aug. 22, 2023 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven Tue, 22 Aug 2023 10:05:00 +0000 6c1e95b7905d78e0f79f5336f8816f35 https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/sophia-genetics-expands-relationship-with-gustave-roussy With the help of the SOPHiA DDM™ Platform, IRST has introduced a new diagnostic kit that will support data- driven treatment planning for a dvanced ovarian cancer BOSTON and ROLLE, Switzerland , Sept. 7, 2023 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a Thu, 07 Sep 2023 10:22:00 +0000 f24486dc0d2c407704a834c5ce251fb6 https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/sophia-genetics-announces-the-irccs-istituto-romagnolo-per-lo-studio-dei-tumori-irst-is-live-on-the-sophia-ddm-platform The SOPHiA DDM™ Platform will help Laboratorio Curie advance its research into BRCA gene mutations BOSTON and ROLLE, Switzerland , Sept. 13, 2023 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, has expanded its relationship with Wed, 13 Sep 2023 14:05:00 +0000 96f4836cc4bd3846ee433a833fdc8174 https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/laboratorio-curie-expands-relationship-with-sophia-genetics The three companies will collaborate to improve global access to advanced cancer testing and data, broadening access to cutting-edge science BOSTON and ROLLE, Switzerland , Oct. 18, 2023 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a category-defining software company and a global leader in The three companies will collaborate to improve global access to advanced cancer testing and data, broadening access to cutting-edge science BOSTON and ROLLE, Switzerland , Oct. 18, 2023 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a category-defining software company and a global leader in Wed, 18 Oct 2023 12:00:00 +0000 6cd8254c595b2351e8de10f4dd51443b https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/sophia-genetics-enters-new-collaboration-with-memorial-sloan-kettering-cancer-center-and-astrazeneca-to-address-global-inequalities-in-comprehensive-cancer-care BOSTON and GENEVA, Switzerland, Oct. 24, 2023 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced it will release its financial results for the third quarter of fiscal 2023 before U.S. Tue, 24 Oct 2023 09:50:07 +0000 e3720f5bb59e94aea3f379e8100afd28 https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/sophia-genetics-to-announce-financial-results-for-the-third-quarter-of-fiscal-2023-on-november-7-2023 Record results on growth acceleration, significant improvement in operating loss and cash burn BOSTON and ROLLE, Switzerland, Nov. 07, 2023 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today reported financial results Tue, 07 Nov 2023 11:30:36 +0000 d2f2d58aba0036645ac91cd66d3ea452 https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/sophia-genetics-reports-financial-results-for-the-third-quarter-of-fiscal-2023 Largest health center in Italy uses SOPHiA DDM™ Platform on Microsoft Azure to expand data-driven medicine capabilities while ensuring accuracy and security BOSTON and ROLLE, Switzerland , Nov. 28, 2023 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the Tue, 28 Nov 2023 12:00:00 +0000 a24a383b6213c255bdd0ce428d0fe617 https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/sophia-genetics-expands-relationship-with-citta-della-salute-e-della-scienza-di-torino BOSTON and ROLLE, Switzerland, Dec. 14, 2023 (GLOBE NEWSWIRE) -- SOPHiA GENETICS (NASDAQ: SOPH) today announced that Jurgi Camblong, PhD., Chief Executive Officer and Co-founder, is scheduled to present at the J.P. Morgan 2024 Healthcare Conference on Thursday, January 11, 2024, at 9:00 a.m. Thu, 14 Dec 2023 17:43:59 +0000 4e3c87c8fda9fa78f5186a9dd4a094b9 https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/sophia-genetics-to-present-at-the-j-p-morgan-2024-healthcare-conference RareCyte will use the SOPHiA DDM™ Platform to support its oncology testing panel BOSTON and ROLLE, Switzerland , Jan. 18, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced that RareCyte Inc. Thu, 18 Jan 2024 20:00:00 +0000 c22946e760323120123848ba5e315a36 https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/sophia-genetics-enhances-rarecyte-precision-biology-services-portfolio SOPHiA GENETICS technology helps advance cancer research across India SOPHiA GENETICS and Karkinos Healthcare join forces to propel cutting-edge genomic solutions for breakthroughs in personalized cancer care in India BOSTON and ROLLE, Switzerland , Jan. Mon, 15 Jan 2024 04:00:00 +0000 4d47a1e96194cf88ea1ed9b07d63558a https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/sophia-genetics-and-karkinos-healthcare-forge-strategic-partnership-to-advance-cancer-research-in-india Strong SOPHiA DDM™ adoption and analysis volume contributes to continued revenue growth Liquid biopsy and HRD on SOPHiA DDM™ Platform continue to grow year-over-year, with Tennessee Oncology, Dasa and The Royal Marsden announced today BOSTON and ROLLE, Switzerland , Jan. Wed, 10 Jan 2024 22:15:00 +0000 a8887b3f4c21884b572a8a56b9755b82 https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/sophia-genetics-highlights-near-term-growth-strategy-at-42nd-annual-j-p-morgan-healthcare-conference Insights from multimodal datasets on the platform fuel cancer research in Canada BOSTON and ROLLE, Switzerland , Jan. 8, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced a collaboration with Exactis Mon, 08 Jan 2024 14:08:00 +0000 525dfd03e97f7657fe3815e14ff8ea82 https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/exactis-innovation-and-sophia-genetics-announce-collaboration-on-multimodal-data-analytics The Hospital will use SOPHiA GENETICS technology to streamline workflows and expedite research BOSTON and ROLLE, Switzerland , Dec. 21, 2023 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced that Hôpital Saint-Louis Thu, 21 Dec 2023 12:00:00 +0000 2eed690c3451c09598e9d014c86f4787 https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/hopital-saint-louis-implements-sophia-ddm-platform-to-further-research-of-myeloid-disorders The company announced Bioma4me has implemented SOPHiA DDM™ to support its rare disorder testing capabilities BOSTON and ROLLE, Switzerland , Jan. 25, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, Thu, 25 Jan 2024 15:50:00 +0000 9782a1cead4724719a38e70ca90f42c6 https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/sophia-genetics-supports-genetic-testing-in-brazil SOPHiA GENETICS and AstraZeneca Spain expand HRD testing program to support molecular diagnosis of ovarian cancer in Spain BOSTON and ROLLE, Switzerland and MADRID , Feb. 7, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven Wed, 07 Feb 2024 11:51:00 +0000 c8f12032860beb59b06a0ee8c945846e https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/sophia-genetics-and-astrazeneca-spain-commit-to-increasing-ovarian-cancer-testing-in-spain BOSTON and ROLLE, Switzerland, Feb. 22, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced Co-founder and Chief Executive Officer, Dr. Jurgi Camblong, and Chief Financial Officer and Chief Operating Officer, Thu, 22 Feb 2024 13:45:07 +0000 b5d5bb47a768f772715686359ff1b824 https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/sophia-genetics-to-participate-in-fireside-chat-at-the-44th-annual-td-cowen-health-care-conference BOSTON and ROLLE, Switzerland , Feb. 22, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced Co-founder and Chief Executive Officer, Dr. Jurgi Camblong, and Chief Financial Officer and Chief Operating Thu, 22 Feb 2024 13:45:00 +0000 53d4a42bdba918d105dc5f1b39a3cbf1 https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/sophia-genetics-to-participate-in-fireside-chat-at-the-44th-annual-td-cowen-health-care-conference-32a21437-24cd-4bf6-823f-7db606008306 BOSTON and ROLLE, Switzerland, Feb. 20, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced it will release its financial results for the fourth quarter and full-year 2023 before U.S. Tue, 20 Feb 2024 15:46:54 +0000 1fc4b1116a145be3bf5df96327a49b1c https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/sophia-genetics-to-announce-financial-results-for-the-fourth-quarter-and-full-year-2023-on-march-5-2024 BOSTON and ROLLE, Switzerland, March 07, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced Chief Financial Officer and Chief Operating Officer, Ross Muken, will participate in a fireside chat at the Thu, 07 Mar 2024 17:08:08 +0000 c70d7b033aac92f0e43b371399853482 https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/sophia-genetics-to-present-at-the-barclays-26th-annual-global-healthcare-conference BOSTON and ROLLE, Switzerland , March 07, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced Chief Financial Officer and Chief Operating Officer, Ross Muken , will participate in a fireside chat at the Thu, 07 Mar 2024 17:07:00 +0000 2b530a3a2a81793333b263a6177bcf61 https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/sophia-genetics-to-present-at-the-barclays-26th-annual-global-healthcare-conference-dfc4103e-d685-4600-94b8-9bf7062f9826 Strong momentum to continue in 2024 as SOPHiA GENETICS announces record revenue, 35 new customer additions in Q4, and 36% cash burn decline in FY 2023 BOSTON and ROLLE, Switzerland, March 05, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in Tue, 05 Mar 2024 11:45:50 +0000 2a448982e36ba5692c2007c205bc6127 https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/sophia-genetics-reports-fourth-quarter-and-full-year-2023-results Strong momentum to continue in 2024 as SOPHiA GENETICS announces record revenue, 35 new customer additions in Q4, and 36% cash burn decline in FY 2023 BOSTON and ROLLE, Switzerland , March 05, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in Tue, 05 Mar 2024 11:45:00 +0000 51dd65e3b112a8ad8ecdf1f75f2a47a9 https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/sophia-genetics-reports-fourth-quarter-and-full-year-2023-results-fc26c4b0-0b1f-4223-8cb1-f070682b84c2 University of Saskatchewan's (USask) Advanced Diagnostics Research Laboratory will use SOPHiA DDM™  Platform to advance research on ovarian cancer care BOSTON and ROLLE, Switzerland , March 20, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in Wed, 20 Mar 2024 14:00:00 +0000 02f2024d84e74be746c6dffc4d97e8ab https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/sophia-genetics-announces-first-homologous-recombination-deficiency-hrd-customer-in-canada Microsoft Azure to Adopt NVIDIA Grace Blackwell Superchip to Accelerate Customer and First-Party AI Offerings NVIDIA DGX Cloud’s Native Integration with Microsoft Fabric to Streamline Custom AI Model Development with Customer’s Own Data NVIDIA Omniverse Cloud APIs First on Azure Power Ecosystem of Mon, 18 Mar 2024 13:00:00 +0000 e9dec1b162703d4d32beb223f139880d https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/microsoft-and-nvidia-announce-major-integrations-to-accelerate-generative-ai-for-enterprises-everywhere New Multimodal Algorithm Highlights Predictive Benefit Of Artificial Intelligence (AI) for Cancer Research BOSTON and ROLLE, Switzerland , March 15, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, and the French Kidney Fri, 15 Mar 2024 10:00:00 +0000 636d9973f9538781deb79d7ca3e11811 https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/sophia-genetics-and-the-french-kidney-cancer-research-network-uroccr-publish-results-from-multiyear-collaboration The companies will join forces to advance the use of precision medicine on a global scale BOSTON and ROLLE, Switzerland , April 4, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced a Thu, 04 Apr 2024 05:00:00 +0000 c231b279d8c216d9a0e0caf23d674a9d https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/sophia-genetics-and-strand-life-sciences-announce-new-strategic-partnership The Chile -based Laboratory is using SOPHiA GENETICS' platform to advance its research capabilities with blood disorders BOSTON and ROLLE, Switzerland , April 2, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today Tue, 02 Apr 2024 14:00:00 +0000 6a9760ee7f058d57ce41e91274aabaad https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/laboratorio-barnafi-krause-is-live-on-sophia-ddm European-based Unilabs has deployed the SOPHiA DDM™ Platform across its network in Switzerland to support cancer diagnostics and treatment BOSTON and ROLLE, Switzerland , April 17, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven Wed, 17 Apr 2024 10:05:00 +0000 634be95eb6873e28edf09cb00251a9d4 https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/sophia-genetics-announces-unilabs-is-using-its-ai-technology-to-detect-homologous-recombination-deficiency-hrd BOSTON and ROLLE, Switzerland, April 23, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS, a cloud-native software company and a leader in data-driven medicine, today announced it will release its financial results for the first quarter of fiscal year 2024 before U.S. markets open on Tuesday, May 7, 2024. Tue, 23 Apr 2024 14:30:32 +0000 9127ca37df2c234e8513b855059e8e78 https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/sophia-genetics-to-announce-financial-results-for-first-quarter-2024-on-may-7-2024 BOSTON and ROLLE, Switzerland , April 23, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS , a cloud-native software company and a leader in data-driven medicine, today announced it will release its financial results for the first quarter of fiscal year 2024 before U.S. Tue, 23 Apr 2024 14:29:00 +0000 dd77d6a1b9c0fd802734550faa44c5c2 https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/sophia-genetics-to-announce-financial-results-for-first-quarter-2024-on-may-7-2024-7170a8d8-a541-414e-b1e9-a5bdc31b5ff4 Syndicate Bio to implement new liquid biopsy offering to advance cancer diagnostics throughout Africa BOSTON and ROLLE, Switzerland , April 23, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today Tue, 23 Apr 2024 09:05:00 +0000 ae2f07fa14447d4e8540d7e372865016 https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/sophia-genetics-announces-syndicate-bio-as-first-liquid-biopsy-customer-in-africa BOSTON and ROLLE, Switzerland, April 30, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS, a cloud-native software company and a leader in data-driven medicine, today announced that Chief Financial Officer and Chief Operating Officer, Ross Muken, will present at the 2024 RBC Capital Markets Global Tue, 30 Apr 2024 11:05:29 +0000 2b0f9a9959f10f2f0286b3532ee5b633 https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/sophia-genetics-to-present-at-the-2024-rbc-capital-markets-global-healthcare-conference BOSTON and ROLLE, Switzerland , April 30, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS , a cloud-native software company and a leader in data-driven medicine, today announced that Chief Financial Officer and Chief Operating Officer, Ross Muken , will present at the 2024 RBC Capital Markets Global Tue, 30 Apr 2024 11:05:00 +0000 c743fd86af6ab8f9f7c3366c9766b5aa https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/sophia-genetics-to-present-at-the-2024-rbc-capital-markets-global-healthcare-conference-66ea4bcb-cf91-403f-8e90-aa575125d333 Consistent Operational Execution; Robust New Business Momentum; Guidance Reaffirmed BOSTON and ROLLE, Switzerland, May 07, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and leader in data-driven medicine, today reported financial results for the first Tue, 07 May 2024 10:45:28 +0000 9840eb177fc29167754bee1f50ca66af https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/sophia-genetics-reports-first-quarter-2024-results Consistent Operational Execution; Robust New Business Momentum; Guidance Reaffirmed BOSTON and ROLLE, Switzerland , May 07, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and leader in data-driven medicine, today reported financial results for the first Tue, 07 May 2024 10:45:00 +0000 e4fb022359af607551002735e9f5df65 https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/sophia-genetics-reports-first-quarter-2024-results-665b2cc9-81b2-4d50-aaa7-dc58766fba43 The SOPHiA DDM™ Platform will help broaden the hospital's cancer testing and diagnostic capabilities BOSTON and ROLLE, Switzerland , May 16, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced that Klinikum Thu, 16 May 2024 10:02:00 +0000 4bf52c3892479c78a791f8280907d25d https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/klinikum-klagenfurt-am-worthersee-is-live-with-sophia-genetics In collaboration with Microsoft and NVIDIA, SOPHiA GENETICS is developing a comprehensive whole genome analytical solution BOSTON and ROLLE, Switzerland , May 29, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven Wed, 29 May 2024 14:00:00 +0000 22fdcb5601c7b4766327330b548ffefe https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/sophia-genetics-to-launch-new-whole-genome-sequencing-capabilities The hospital will enhance its testing and research of blood cancers with the SOPHiA DDM™ Platform BOSTON and ROLLE, Switzerland , May 20, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced Mon, 20 May 2024 14:02:00 +0000 83b1628fd3ce8470c14da9414a22d810 https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/sophia-genetics-announces-instituto-mario-penna-as-new-customer New collective intelligence network to enable the most advanced research in oncology in support of precision medicine BOSTON and ROLLE, Switzerland , May 30, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven Thu, 30 May 2024 16:19:00 +0000 6361d9db534d7e64eed70c495313853a https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/sophia-genetics-launches-global-consortium-sophia-unity-to-accelerate-cancer-research-drug-development-and-data-driven-patient-care The Hospital will use SOPHiA DDM™ to enhance its testing and research of blood cancers BOSTON and ROLLE, Switzerland , June 13, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a leader in data-driven medicine, today announced that Kepler Thu, 13 Jun 2024 10:00:00 +0000 a62173a9d4b39cb4fcb02f48fd404e22 https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/sophia-genetics-announces-kepler-uniklinikum-is-live-on-sophia-ddm-platform Novel application supports measurable residual disease (MRD) testing to help monitor cancer and stay ahead of relapse BOSTON and ROLLE, Switzerland , June 24, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven Mon, 24 Jun 2024 06:00:00 +0000 8117b75e25e9eae1a080367d91636104 https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/sophia-genetics-launches-new-residual-acute-myeloid-ram-application Shareholders adopt all proposals at Annual General Meeting BOSTON and ROLLE, Switzerland, June 24, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a healthcare technology company and a leader in data-driven medicine, is pleased to announce that its annual general meeting of shareholders Mon, 24 Jun 2024 13:48:29 +0000 26aa152d46948158bc142c33d6456ce0 https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/sophia-genetics-publishes-results-of-2024-annual-general-meeting Shareholders adopt all proposals at Annual General Meeting BOSTON and ROLLE, Switzerland , June 24, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a healthcare technology company and a leader in data-driven medicine, is pleased to announce that its annual general meeting of Mon, 24 Jun 2024 13:47:00 +0000 23172d7179d5a5ecd519f20cf76f1091 https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/sophia-genetics-publishes-results-of-2024-annual-general-meeting-ce2f3dcd-602c-440f-bf6a-0bc35b8e0688 The diagnostics company has implemented the SOPHiA DDM ™  Platform to enhance its solid tumor testing BOSTON and ROLLE, Switzerland , July 4, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today Thu, 04 Jul 2024 06:30:00 +0000 68ba77dcc370de1a544bc603c4cb1be3 https://careers.sophiagenetics.com/blogs/sophia-genetics-inc-news-releases/india-based-dhiti-omics-is-now-live-on-sophia-ddm